HempStreet, India's first research to retail venture in the ayurvedic cannabis sector has partnered with Gynica, an R&D company based out of Israel focused on changing the culture of gynaecological treatment through clinically proven, cannabinoid-based solutions. The partnership will benefit the companies to strengthen their R&D capabilities and to develop clinically-proven, robust phytopharmaceutical products to improve menstrual health and tackle other mass ailments.
Established in 2019, HempStreet has been leveraging the growing popularity of the age-old science of Ayurveda to manufacture
